<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Shailza Singh</submitter><journal>Frontiers in Genetics</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/MODEL2012040002</full_dataset_link><repository>biostudies-other</repository><additional_accession>10.3389/fgene.2021.784664</additional_accession><pubmed_authors>Rahuman S Malik-Sheriff</pubmed_authors><pubmed_authors>Shailza Singh</pubmed_authors></additional><is_claimable>false</is_claimable><name>Khandibharad2022 - IL-12 regulation by IL-10 in Leishmaniasis</name><description>&lt;notes xmlns="http://www.sbml.org/sbml/level2">      &lt;body xmlns="http://www.w3.org/1999/xhtml">     &lt;p>In this model, TLR2-TLR6 mediates MyD88 pathway gets activated, which activates IL-12 production and induces iNOS expression when the Macrophage is infected with Leishmania parasite. The early induction of IL-10 takes place which leads to the induction of NFIL3, HDAC3, and SHP-1. They inhibit IL-12 production and thus hamper IL-12 induced IFN-gamma mediated; Nitric oxide production. A key transcription factor NFAT5  connects IL-12 and IL-10 pathways. It upregulates IL-12 and downregulates IL-10. In this model, NFAT5 is downregulated which is also inhibiting IL-12.&lt;/p>  &lt;/body>    &lt;/notes></description><dates><release>2020-12-04T00:00:00Z</release><modification>2025-07-14T17:41:08.744Z</modification><creation>2025-03-30T22:54:58.343Z</creation></dates><accession>MODEL2012040002</accession><cross_references><mamo>MAMO_0000046</mamo><doi>10.3389/fgene.2021.784664</doi></cross_references></HashMap>